Press Releases

Jun 04, 2021 7:00am EDT

CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs

May 27, 2021 7:00am EDT

CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million

May 25, 2021 9:00am EDT

CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs

Mar 29, 2021 7:00am EDT

CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors

Mar 26, 2021 9:00am EDT

CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020

Mar 04, 2021 7:00am EST

CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference

Feb 25, 2021 9:20am EST

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

Feb 18, 2021 9:31am EST

CollPlant Issues Letter to Shareholders

Feb 18, 2021 7:00am EST

CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares

Feb 11, 2021 11:22pm EST

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares